SYMPHONY.BOSYMPHONY.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -2.02% | +46.99% | -52.73% | -48.25% | -26.03% |
| Gross Profit Growth | +3.42% | +79.37% | -46.35% | -55.93% | -47.93% |
| EBITDA Growth | -116.95% | +78.27% | -45.83% | -55.95% | +0.00% |
| Operating Income Growth | +105.26% | +503.92% | -77.36% | -63.79% | -60.26% |
| Net Income Growth | -124.39% | +64.14% | -52.27% | -66.07% | +0.00% |
| EPS Growth | -123.18% | +62.25% | -52.35% | -65.84% | +0.00% |
| EPS Diluted Growth | -123.18% | +62.25% | -52.35% | -65.84% | +0.00% |
| Weighted Average Shares Growth | +5.85% | +1.44% | +0.18% | -0.55% | -8.67% |
| Weighted Average Shares Diluted Growth | +5.85% | +1.44% | +0.18% | -0.55% | -8.67% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -15.42% | +0.00% | -95.83% | +0.00% |
| Inventory Growth | +0.00% | +15.17% | +0.00% | -34.55% | +0.00% |
| Asset Growth | +0.00% | +9.52% | +0.00% | -3.14% | +0.00% |
| Book Value per Share Growth | +1.27% | +0.16% | +1.36% | +7.85% | +0.00% |
| Debt Growth | +0.00% | -16.42% | +0.00% | -95.93% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -74.29% | -24.00% | -65.35% | -48.33% | +33.33% |